FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2556003798> ?p ?o ?g. }

• W2556003798 abstract "Abstract The drug resistance gene MGMT(P140K) mutant has been extensively studied as a means to protect/select hematopoietic stem cells (HSC) following treatment with O6-alkylating agents such as temozolomide (TMZ) in tandem with the inhibitor of endogenous MGMT, O6-benzylguanine (6BG). Since the repair of O6-alkyl adducts by MGMT is stoichiometric, it has been suggested that higher levels of MGMT(P140K) will confer better protection upon HSC. To test this hypothesis, we developed a panel of SIN γ-retroviral vectors which express low to very high levels of MGMT(P140K) via different internal promoters. The MGMT activity in bone marrow cells (BMC) transduced with a viral LTR-derived promoter, SF(MGMT), was approximately 7-fold higher than in cells transduced with either cellular promoters PGK(MGMT) or EFS(MGMT) which were in turn &gt;300-fold higher than in control transduced cells (CON). Mice transplanted with transduced BMC were treated with 6BG (30mg/kg) and TMZ (80mg/kg) on 3 consecutive days starting 7 weeks post-transplant. Surprisingly, we found that selection/protection was not evident in mice engrafted with SF(MGMT) transduced BMC, while robust long term in vivo selection/protection was observed in mice transduced with PGK(MGMT) and EFS(MGMT) BMC (Table 1). We next sought to explore the mechanism of these findings. 2 hours after 6BG/TMZ treatment, BMC harvested from SF-, PGK- and EFS(MGMT) groups showed equivalent repair of the O6-alkylguanine lesion. Thus, lower MGMT expression is adequate for O6-alkylguanine lesion repair, and the lack of selection by SF(MGMT) is not related to defective repair. In the absence of chemoselection, we found a modest but statistically significant decrease in the in vivo reconstitution of SF(MGMT)-transduced BMC compared to EFS- or PGK- transduced BMC in a competitive repopulation assay, while secondary recipients showed a more pronounced engraftment defect (18- and 32-fold lower engraftment of SF(MGMT) vs EFS(MGMT), (p&lt;0.05) or PGK(MGMT), (p&lt;0.01) respectively). To further examine this repopulation defect, 32D cells were transduced with SF(MGMT) and demonstrated a growth defect in vitro (Table 2), have &gt;40% reduced colony forming ability (p&lt;0.01) and show &gt;30% reduced 3H thymidine uptake (p&lt;0.01), but do not demonstrate an elevated rate of apoptosis.These data strongly suggest that very high expression of MGMT(P140K) has a deleterious effect upon cellular proliferation, engraftment and chemoprotection. Since clinical gene therapy studies with MGMT(P140K) are underway these studies have direct translational relevance. Table 1. Chemoselection/Protection in vivo mean ± SEM % PBC pre-treatment % change PBC 15 weeks post-treatment WBC (×10e6/ml) pre-treatment WBC (×10e6/ml) 7 weeks post-treatment (**p&lt;0.01 compared to non-treated) CON 49.5±3.8 −11.4±5.1 12.3±1.0 5.4±0.3** SF-MGMT 57.3±2.4 −18.3±7.3 11.7±0.8 8.6±1.1** EFS-MGMT 39.3±3.2 +18.8±4.4** 12.9±1.1 13.5±1.3 PGK-MGMT 46.8±4.4 +27.9±2.9** 12.2±0.8 12.5±1.1 Table 2. Growth of transduced 32D cells in the absence of treatment CON EFS-MGMT PGK-MGMT SF-MGMT (**p&lt;0.01 for SF vs. CON, EFS and PGK) % GFP+ after 28d culture 101.8±14.5 91.6±2.8 98.4±19.4 31.2±3.2**" @default.
• W2556003798 created "2016-11-30" @default.
• W2556003798 creator A5005689665 @default.
• W2556003798 creator A5009921816 @default.
• W2556003798 creator A5037368020 @default.
• W2556003798 creator A5041017961 @default.
• W2556003798 creator A5044633818 @default.
• W2556003798 creator A5045547014 @default.
• W2556003798 creator A5054362291 @default.
• W2556003798 creator A5056346259 @default.
• W2556003798 creator A5067898898 @default.
• W2556003798 creator A5077801086 @default.
• W2556003798 date "2007-11-16" @default.
• W2556003798 modified "2023-09-28" @default.
• W2556003798 title "Very High Expression of MGMT(P140K) Paradoxically Impairs Proliferation, In Vivo Selection and Protection of Transduced Hematopoietic Stem Cells." @default.
• W2556003798 doi "https://doi.org/10.1182/blood.v110.11.2588.2588" @default.
• W2556003798 hasPublicationYear "2007" @default.
• W2556003798 type Work @default.
• W2556003798 sameAs 2556003798 @default.
• W2556003798 citedByCount "0" @default.
• W2556003798 crossrefType "journal-article" @default.
• W2556003798 hasAuthorship W2556003798A5005689665 @default.
• W2556003798 hasAuthorship W2556003798A5009921816 @default.
• W2556003798 hasAuthorship W2556003798A5037368020 @default.
• W2556003798 hasAuthorship W2556003798A5041017961 @default.
• W2556003798 hasAuthorship W2556003798A5044633818 @default.
• W2556003798 hasAuthorship W2556003798A5045547014 @default.
• W2556003798 hasAuthorship W2556003798A5054362291 @default.
• W2556003798 hasAuthorship W2556003798A5056346259 @default.
• W2556003798 hasAuthorship W2556003798A5067898898 @default.
• W2556003798 hasAuthorship W2556003798A5077801086 @default.
• W2556003798 hasConcept C104317684 @default.
• W2556003798 hasConcept C109159458 @default.
• W2556003798 hasConcept C203014093 @default.
• W2556003798 hasConcept C207001950 @default.
• W2556003798 hasConcept C2776194525 @default.
• W2556003798 hasConcept C2777389519 @default.
• W2556003798 hasConcept C2780007613 @default.
• W2556003798 hasConcept C28328180 @default.
• W2556003798 hasConcept C32470452 @default.
• W2556003798 hasConcept C40767141 @default.
• W2556003798 hasConcept C502942594 @default.
• W2556003798 hasConcept C54355233 @default.
• W2556003798 hasConcept C86803240 @default.
• W2556003798 hasConcept C95444343 @default.
• W2556003798 hasConceptScore W2556003798C104317684 @default.
• W2556003798 hasConceptScore W2556003798C109159458 @default.
• W2556003798 hasConceptScore W2556003798C203014093 @default.
• W2556003798 hasConceptScore W2556003798C207001950 @default.
• W2556003798 hasConceptScore W2556003798C2776194525 @default.
• W2556003798 hasConceptScore W2556003798C2777389519 @default.
• W2556003798 hasConceptScore W2556003798C2780007613 @default.
• W2556003798 hasConceptScore W2556003798C28328180 @default.
• W2556003798 hasConceptScore W2556003798C32470452 @default.
• W2556003798 hasConceptScore W2556003798C40767141 @default.
• W2556003798 hasConceptScore W2556003798C502942594 @default.
• W2556003798 hasConceptScore W2556003798C54355233 @default.
• W2556003798 hasConceptScore W2556003798C86803240 @default.
• W2556003798 hasConceptScore W2556003798C95444343 @default.
• W2556003798 hasLocation W25560037981 @default.
• W2556003798 hasOpenAccess W2556003798 @default.
• W2556003798 hasPrimaryLocation W25560037981 @default.
• W2556003798 hasRelatedWork W1965699576 @default.
• W2556003798 hasRelatedWork W1978598034 @default.
• W2556003798 hasRelatedWork W2021591120 @default.
• W2556003798 hasRelatedWork W2091184152 @default.
• W2556003798 hasRelatedWork W2162587612 @default.
• W2556003798 hasRelatedWork W2253242983 @default.
• W2556003798 hasRelatedWork W2412102303 @default.
• W2556003798 hasRelatedWork W2414374203 @default.
• W2556003798 hasRelatedWork W2785887317 @default.
• W2556003798 hasRelatedWork W325523310 @default.
• W2556003798 isParatext "false" @default.
• W2556003798 isRetracted "false" @default.
• W2556003798 magId "2556003798" @default.
• W2556003798 workType "article" @default.